Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
118 Cards in this Set
- Front
- Back
Indomethacin
|
COX-I
|
|
Alprostadil
|
PGE1
Keep ductus open; impotence |
|
Misoprostol
|
PGE1
Prevent GI ulcers |
|
Dinoprostone
|
PGE2
Labour & abortion |
|
Carboprost, dinoprost
|
PGF2
Labour & abortion |
|
Epoprostinol
|
PGI1
Prevent clotting; vasodilation |
|
Auranofin
Sodium aurothiomalate |
Inhibit immune cell activity
Disease-modifying in rheumatoid arthritis |
|
Methotrexate
|
Rheumatoid arthritis
|
|
Sulfasalazine
|
Rheumatoid arthritis
|
|
Hydroxychloroquine
|
Rheumatoid arthritis
|
|
TNFalpha, IL-1 monoclonal Abs
|
Rheumatoid arthritis
|
|
Aspirin
|
COX1&2 inhibitor
|
|
Diclofenac
|
COX1&2 inhibitor
|
|
Fenoprofen
|
COX1&2 inhibitor
|
|
Flurbiprofen
|
COX1&2 inhibitor
|
|
Indomethacin
|
COX1&2 inhibitor
|
|
Naproxen
|
COX1&2 inhibitor
|
|
Piroxicam
|
COX1&2 inhibitor
|
|
Celecoxib
|
COX2 inhibitor
|
|
Etodolac
|
COX2 inhibitor
|
|
Meloxicam
|
COX2 inhibitor
|
|
Rofecoxib
|
COX2 inhibitor (highly selective)
|
|
5-ASA
|
COX1&2 inhibitor
|
|
Diflunisal
|
COX1&2 inhibitor
|
|
Sodium salicylate
|
COX1&2 inhibitor
|
|
Nabumetone
|
COX1&2 inhibitor
|
|
Sulphalazine
|
COX1&2 inhibitor
|
|
Acetaminophen
|
FAAH conjufation, central TRPV1 agonist
|
|
Diphenhydramine
|
H1 antagonist
1st gen Allergies, colds |
|
Loratadine
|
H1 antagonist
2nd gen Allergies, colds |
|
Terfenadine
|
H1 antagonist
2nd gen Allergies, colds |
|
Cimetidine
|
H2 antagonist
PUD, GERD |
|
Ranitidine
|
H2 antagonist
PUD, GERD |
|
Epinephrine
|
Beta agonist
Acute asthma Increase local anesthetic duration of action |
|
Ephedrine
|
Beta agonist
Acute asthma Increase local anesthetic duration of action |
|
Isoproterenol
|
Acute asthma
|
|
Albuterol
|
Acute asthma
Beta2 agonist |
|
Terbutaline, fenoterol
|
Beta2 agonist
|
|
Salmeterol
|
Beta2 agonist
|
|
Formeterol
|
Beta2 agonist
|
|
Theophylline
|
Methylxanthine
Asthma |
|
Theobromine
|
Methylxanthine
Asthma |
|
Roflumilast
|
Methylxanthine
Asthma and COPD (especially) |
|
Atropine, ipratropium bromide
|
Muscarinic antagonist
Resistant asthma; COPD |
|
Beclomethasone
|
Asthma (chronic)
|
|
Flunisolide
|
Asthma (chronic)
Corticosteroid |
|
Triamcinolone
|
Asthma (chronic)
Corticosteroid |
|
Ciclesonide
|
Asthma (chronic)
Corticosteroid |
|
Zileuton
|
Asthma (chronic)
Inhibit 5-lipoxygenase (leukotrienes) |
|
Zafirlukast, montelukast
|
Asthma (chronic)
Inhibit LTD4 R binding |
|
Cromolyn, nedrocromil
|
Asthma (chronic)
Alter Cl- channel to inhibit mast cell activation |
|
Omalizumab
|
Asthma (chronic)
IgE monoclonal Ab |
|
Alpha-1 antitrypsin
|
COPD (congenital AAT deficiency)
|
|
Digoxin
|
Heart failure
Inhibit Na+/K+ ATPase |
|
Dobutamine
|
Heart failure (acute), especially with hypotension
Beta agonist |
|
Inamrinone
|
Heart failure
Phosphodiesterase inhibition |
|
Levosimedan
|
Heart failure
Ca2+ sensitizer |
|
Ivabradine
|
HF, arrhythmias (slow HR)
If channel inhibitor |
|
Quinidine, procainamide, disopyramide
|
Arrhythmia
Int. Na+ channel blockers |
|
Lidocaine, mexiletene
|
Arrhythmia
Fast Na+ channel blocker |
|
Propafenone, flecainide
|
Arrhythmia
Slow Na+ channel blocker |
|
Amiodarone
|
Arrhythmia
K+ channel blocker |
|
Sotalol, sematolide
|
Arrhythmias (slow HR)
K+ channel blocker |
|
Dronedarone
|
Arrhythmia
K+ channel blocker (slow HR) |
|
Azimilide
|
Arrhythmia
K+ channel blocker |
|
Glyceryl trinitrate
|
HF, angina
Activates sGC, increasing cGMP and Ca2+ sequestration Venodilator |
|
Isosorbide dinitrate
|
HF, angina
Activates sGC, increasing cGMP and Ca2+ sequestration Venodilator |
|
Sodium nitroprusside
|
HT emergency, mitral/aortic regurgitation
NO donor Balanced dilator |
|
Nesiritide
|
HF
BNP analog to increase cGMP Venodilator |
|
Hydralazine
|
Hypertension, HF, kidney disease
Decrease cGMP, IP3, Ca2+ Arterial |
|
Furosemide
|
Loop diuretic
Inhibit Na+/K+/2Cl- cotransporter in distal ascending tubule |
|
Bumetanide
|
Loop diuretic
|
|
Torasemide
|
Loop diuretic
|
|
Chlorothiazide
|
HT, mild-moderate CHF, kidney disease
Thiazide diuretic |
|
Chlorthalidone
|
Thiazide diuretic
|
|
Acetazolamide
|
Glaucoma, respiratory alkalosis, HT/CHF
Inhibit bicarbonate reabsorption |
|
Spironolactone
|
Hepatic cirrhosis, CHF
K+ sparing diuretic Aldosterone R antagonist |
|
Trimeterene, amiloride
|
K+ sparing diuretic
Na+ pore antagonist |
|
Mannitol, urea
|
Brain edema, CV surgery, renal failure
Osmotic diuretic |
|
Propranolol, metoprolol, atenolol, pindolol
|
HT
|
|
Prazosin, phentolamine, labetalol
|
HT
|
|
Methyldopa, clonidine, reserpine
|
Resistant HT
Indirect sympethetic antagonists |
|
Nifedipine
|
HT
DHP Ca2+ channel blocker |
|
Verapamil
|
HT
Non-DHP Ca2+ channel blocker |
|
Captopril, enalapril
|
HT
ACE-Is |
|
Losartan
|
HT
Angiotensin receptor blocker |
|
Aliskiren
|
HT
Renin inhibitor (potential) |
|
Minoxidil
|
HT
Vasodilator -- increase opening time of K+ channel |
|
Atorvastatin, fluvastatin, lovastatin, pravastatin, simvastatin, rosuvastatin
|
Hyperlipoproteinemias
Inhibit HMg-CoA reductase |
|
Cholestyramine, colestipol
|
Hyperlipoproteinemias
Cationic resin - prevent intestinal bile acid absorption |
|
Neomycin
|
Hyperlipoproteinemias
Prevent intestinal bile acid absorption |
|
Ezetimibe
|
Hyperlipoproteinemias
Prevent intestinal absorption of dietary, biliary cholesterol (NPC1L) |
|
Nicotinic acid (niacin)
|
Hyperlipoproteinemias
Inhibit FFA release from adipose |
|
Clofibrate, fenofibrate, gemfibrozil
|
Hyperlipoproteinemias
Stimulate PPAR-alpha activity |
|
Cholestyramine, colestipol
|
Hyperlipoproteinemias
Cationic resin - prevent intestinal bile acid absorption |
|
Neomycin
|
Hyperlipoproteinemias
Prevent intestinal bile acid absorption |
|
Ezetimibe
|
Hyperlipoproteinemias
Prevent intestinal absorption of dietary, biliary cholesterol (NPC1L) |
|
Dipyridamole
|
Inhibit platelet phosphodiesterase
|
|
Ticlopidine
|
Inhibit ADP binding to platelet receptor --> reduce glycoprotein IIa/IIIb receptor
|
|
Clopidogrel
|
Inhibit ADP binding to platelet receptor --> reduce glycoprotein IIa/IIIb receptor
|
|
Abciximab, eptifibatide, lamifiban, tirofiban
|
GPIIb/IIIa receptor monoclonal Abs
|
|
Heparin
|
Increase anti-thrombin III activity
|
|
Enoxaparin, dalteparin
|
Low MW heparin
|
|
Protamine
|
Heparin antidote
|
|
Hirudin, lepirudin, bivalirudine
|
Inhibit thrombin
|
|
Warfarin
|
Vitamin K antagonist
|
|
Streptokinase, tPA, tenecteplase
|
Plasminogen activator
|
|
Dipyridamole
|
Inhibit platelet phosphodiesterase
|
|
Ticlopidine
|
Inhibit ADP binding to platelet receptor --> reduce glycoprotein IIa/IIIb receptor
|
|
Clopidogrel
|
Inhibit ADP binding to platelet receptor --> reduce glycoprotein IIa/IIIb receptor
|
|
Abciximab, eptifibatide, lamifiban, tirofiban
|
GPIIb/IIIa receptor monoclonal Abs
|
|
Heparin
|
Increase anti-thrombin III activity
|
|
Enoxaparin, dalteparin
|
Low MW heparin
|
|
Protamine
|
Heparin antidote
|
|
Hirudin, lepirudin, bivalirudine
|
Inhibit thrombin
|
|
Warfarin
|
Vitamin K antagonist
|
|
Streptokinase, tPA, tenecteplase
|
Plasminogen activator
|
|
Methylene blue
|
Electron donor to correct methemoglobinemia
|